(Q57578554)

English

Subcutaneously Administered Recombinant Human Interleukin-2 and Interferon Alfa-2a for Advanced Breast Cancer: A Phase II study of the Cancer and Leukemia Group B (CALGB 9041)

scientific article published on 01 January 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Subcutaneously administered recombinant human interleukin-2 and interferon alfa-2a for advanced breast cancer: a phase II study of the Cancer and Leukemia Group B (CALGB 9041) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

0 references

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

2

object named as

Mark J Ratain

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

6

object named as

Hyman B Muss

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Gretchen G Kimmick

1

object named as

Gretchen Kimmick

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Don Berry

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Susan Woolf

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Cancer and Leukemia Group B (CALGB 9041)

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

83-89

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707498%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

The immunology and immunotherapy of breast cancer: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of outpatient interleukin-2 in malignant lymphoma, chronic lymphocytic leukemia, and selected solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon plus tamoxifen treatment for advanced breast cancer: in vivo biologic effects of two growth modulators

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of subcutaneous recombinant interleukin-2 and interferon alfa-2a

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen and alpha interferon in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of interferon alpha-2a on hormone receptor status in patients with advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen and interferon-beta for the treatment of metastatic breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of fibroblast interferon to patients with advanced breast cancer: possible effects on skin metastasis and on hormone receptors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological and side effects of low sc recombinant interleukin-2 dose in addition to conventional treatment in relapsed breast and colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 differentially affects the proliferation of a hormone-dependent and a hormone-independent human breast cancer cell line in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of recombinant alpha-interferon and recombinant interleukin-2 metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of alpha-interferon, 17 beta-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF 7 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural interferon-alpha activity in hormone-sensitive, hormone-resistant and autonomous human breast-cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14707498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57578554&oldid=2213535340"